【摘要】 目的:为临床合理、安全应用抗心律失常药提供参考。方法:收集2002~2005年我国抗心律失常药应用数据,并进行对比分析。结果:抗心律失常药销售金额呈逐年上升趋势,用药频度排序前5位药品各年基本相同,包括普罗帕酮、胺碘酮、美西律、莫雷西嗪和阿普林定。结论:我国抗心律失常药应用较为合理;新的Ⅲ类抗心律失常药的应用有增长趋势。更多还原

【Abstract】 OBJECTIVE: To evaluate the current situation and trends of antiarrhythmic drug use in China and provide references for rational, efficient and economical use of antiarrhythmic drugs in clinic. METHODS: The sales volume, sales amount of antiarrhythmic drugs from 2002 to 2005 in China were investigated and analyzed. RESULTS: The drugs that dominated the first 5 places were almost the same in 4 years, i.e. propafenone, amiodarone, mexiletine, moricizine and aprindine. CONCLUSION: The clinical application of antiarrhythmic drugs in China was rational and Class Ⅲ antiarrhythmic drugs will be more and more popular.更多还原